The platform will undergo maintenance on Sep 14 at about 9:30 AM EST and will be unavailable for approximately 1 hour.
2010
DOI: 10.1016/j.intimp.2009.11.015
|View full text |Cite
|
Sign up to set email alerts
|

Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on scratching behavior in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 28 publications
0
2
0
Order By: Relevance
“…The neuro-protective/ trophic properties of NGF are well established [24, 30, 31], albeit therapeutic applications are currently limited due to pathogenic side effects including neuropathic [4, 5] and deep tissue pain [10, 11] atopic dermatitis [79], arthritis, asthma [10, 12, 13], intervertebral disc degeneration [14] and cancer. [1517] Therefore, there is a need for identification of small MW neurotrophic compounds that may have therapeutic value in treatment of peripheral/CNS injury or neurodegenerative disorders, without the limitations of endogenous neurotrophins.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The neuro-protective/ trophic properties of NGF are well established [24, 30, 31], albeit therapeutic applications are currently limited due to pathogenic side effects including neuropathic [4, 5] and deep tissue pain [10, 11] atopic dermatitis [79], arthritis, asthma [10, 12, 13], intervertebral disc degeneration [14] and cancer. [1517] Therefore, there is a need for identification of small MW neurotrophic compounds that may have therapeutic value in treatment of peripheral/CNS injury or neurodegenerative disorders, without the limitations of endogenous neurotrophins.…”
Section: Discussionmentioning
confidence: 99%
“…While most drug regimens have capacity to improve quality of life, they do not address the underlying etiology of the disease and thereby do not arrest progression degenerative processes. Although endogenous synthesis of trophic molecules such as nerve growth factor (NGF) [1], brain-derived neurotrophic factor (BDNF) and neurotrophin-3/neurotrophin-4 can effectively stimulate neuronal growth/repair [2, 3], therapeutic applications are limited by a wide range of negative side effects such as neuropathic pain [4, 5], bladder/urinary pain [6], itchy skin (pruritus) atopic dermatitis [79], deep tissue tenderness [10, 11], exacerbated inflammatory conditions such as arthritis, asthma [10, 12, 13], inter-vertebral disc degeneration [14] and cancer [1517]. Furthermore, elevated levels of NGF in various neuronal tissue can lead to behavioral/cognitive disorders such as autism [18], bipolar [19] and attention deficit/hyperactivity disorder.…”
Section: Introductionmentioning
confidence: 99%